tiprankstipranks
Arcus Biosciences (RCUS)
:RCUS
US Market

Arcus Biosciences (RCUS) Income Statement

Compare
465 Followers

Arcus Biosciences Income Statement

Last quarter (Q3 2024), Arcus Biosciences's total revenue was $48.00M, an increase of 50.00% from the same quarter last year. In Q3, Arcus Biosciences's net income was $-92.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 117.00M$ 112.00M$ 382.88M$ 77.52M$ 15.00M
Gross Profit
$ -223.00M$ 98.00M$ 375.82M$ -81.48M$ -63.48M
Operating Expenses
$ 457.00M$ 392.00M$ 328.63M$ 201.75M$ 103.71M
Depreciation and Amortization
$ 8.00M$ 14.00M$ 7.06M$ 4.39M$ 3.58M
EBITDA
$ -283.00M$ -250.00M$ 61.96M$ -118.47M$ -81.13M
Operating Income
$ -340.00M$ -280.00M$ 54.25M$ -124.23M$ -88.71M
Other Income/Expenses
$ 39.00M$ 14.00M$ 397.00K$ 1.38M$ 4.00M
Pretax Income
$ -301.00M$ -266.00M$ 54.65M$ -122.86M$ -84.71M
Net Income
$ -307.00M$ -267.00M$ 53.00M$ -116.68M$ -75.93M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.15$ -3.71$ 0.76$ -2.13$ -1.73
Diluted EPS
$ -4.15$ -3.71$ 0.71$ -2.13$ -1.73
Weighted Average Shares Outstanding
74.00M 72.00M 69.35M 54.79M 43.83M
Weighted Average Shares Outstanding (Diluted)
74.00M 72.00M 73.97M 54.79M 43.83M
Currency in USD

Arcus Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis